US patent office issued notification to grant patent to Stempeutics for its stem cell drug… EP News Bureau Nov 11, 2019 Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy Usha Sharma May 30, 2016 Stempeucel is used in the treatment of Buerger’s disease
Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’ Usha Sharma Jun 8, 2015 Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
